BIOMAT Database Logo BIOMAT Database Logo

Inhibition of human neutrophil elastase. 3. An orally active enol acetate prodrug. 1995

J P Burkhart, and J R Koehl, and S Mehdi, and S L Durham, and M J Janusz, and E W Huber, and M R Angelastro, and S Sunder, and W A Metz, and P W Shum
Marion Merrell Dow Research Institute, Cincinnati, Ohio 45215.

Several analogs of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N-[3,3,4,4,4-penta fluoro-1- (1-methylethyl)-2-oxobutyl]-L-prolinamide (1), in which the chiral center of the P1 residue has been eliminated, were synthesized and tested as inhibitors of human neutrophil elastase (HNE). Observations made during the course of this work led to the development of a single-step, stereoselective synthesis of E-enol acetate derivatives from HNE inhibitors containing a mixture of epimers at P1. In vitro studies, in the presence of added esterase, and 19F NMR studies, in biological media, indicated that the E-enol acetate derivatives should act as prodrugs in vivo. The ED50 value for (E)-N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N-[2- (acetyloxy)-3,3,4,4,4-pentafluoro-1-(1-methylethyl)-1-buteny l]-L-prolinamide (20), when administered orally in the hamster lung hemorrhage model, was 9 mg/kg.

UI MeSH Term Description Entries
D007659 Ketones Organic compounds containing a carbonyl group Ketone
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010196 Pancreatic Elastase A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36. Elastase,Pancreatopeptidase,Elastase I,Pancreatic Elastase I,Elastase I, Pancreatic,Elastase, Pancreatic
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J P Burkhart, and J R Koehl, and S Mehdi, and S L Durham, and M J Janusz, and E W Huber, and M R Angelastro, and S Sunder, and W A Metz, and P W Shum
Intracellular inhibition of human neutrophil elastase by orally active pyrrolidine-trans-lactams.
January 2001, Bioorganic & medicinal chemistry letters,
J P Burkhart, and J R Koehl, and S Mehdi, and S L Durham, and M J Janusz, and E W Huber, and M R Angelastro, and S Sunder, and W A Metz, and P W Shum
Development of orally active nonpeptidic inhibitors of human neutrophil elastase.
April 2001, Journal of medicinal chemistry,
J P Burkhart, and J R Koehl, and S Mehdi, and S L Durham, and M J Janusz, and E W Huber, and M R Angelastro, and S Sunder, and W A Metz, and P W Shum
Pharmacological evaluation of selected, orally active, peptidyl inhibitors of human neutrophil elastase.
December 1995, The Journal of pharmacology and experimental therapeutics,
J P Burkhart, and J R Koehl, and S Mehdi, and S L Durham, and M J Janusz, and E W Huber, and M R Angelastro, and S Sunder, and W A Metz, and P W Shum
Design and synthesis of new orally active inhibitors of human neutrophil elastase.
May 2001, Bioorganic & medicinal chemistry,
J P Burkhart, and J R Koehl, and S Mehdi, and S L Durham, and M J Janusz, and E W Huber, and M R Angelastro, and S Sunder, and W A Metz, and P W Shum
Design and synthesis of new orally active nonpeptidic inhibitors of human neutrophil elastase.
December 2000, Journal of medicinal chemistry,
J P Burkhart, and J R Koehl, and S Mehdi, and S L Durham, and M J Janusz, and E W Huber, and M R Angelastro, and S Sunder, and W A Metz, and P W Shum
Discovery and biological activity of orally active peptidyl trifluoromethyl ketone inhibitors of human neutrophil elastase.
June 1997, Journal of medicinal chemistry,
J P Burkhart, and J R Koehl, and S Mehdi, and S L Durham, and M J Janusz, and E W Huber, and M R Angelastro, and S Sunder, and W A Metz, and P W Shum
An inhibitor in human lung macrophages active against human neutrophil elastase.
September 1972, The American review of respiratory disease,
J P Burkhart, and J R Koehl, and S Mehdi, and S L Durham, and M J Janusz, and E W Huber, and M R Angelastro, and S Sunder, and W A Metz, and P W Shum
Orally active trifluoromethyl ketone inhibitors of human leukocyte elastase.
September 1997, Journal of medicinal chemistry,
J P Burkhart, and J R Koehl, and S Mehdi, and S L Durham, and M J Janusz, and E W Huber, and M R Angelastro, and S Sunder, and W A Metz, and P W Shum
Inhibition of human neutrophil elastase by wheat ceramides.
December 1995, International journal of cosmetic science,
J P Burkhart, and J R Koehl, and S Mehdi, and S L Durham, and M J Janusz, and E W Huber, and M R Angelastro, and S Sunder, and W A Metz, and P W Shum
Inhibition of human neutrophil elastase by bacterial polyanions.
January 1988, Experimental lung research,
Copied contents to your clipboard!